Judith Prochaska, PhD, MPH
Stanford Medicine - Stanford University
Location
Conference Seminar 110 - NCI Shady Grove 9609 Medical Center Drive Rockville MD 20850
Date
Tue, 04/25/2017 - 11:0004/25/2017 11:00am 06/27/2017 11:35am Digital Tools for Cancer Prevention: Extending Reach and Engagement Judith (Jodi) Prochaska, PhD, MPH, is Associate Professor of Medicine with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute. Dr. Prochaska is a Principal Investigator on multiple research awards from the National Institutes of Health and the State of California Tobacco-Related Disease Research Program. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. With attention to medical education and clinical practice, Dr. Prochaska has disseminated tobacco treatment curricula as part of Rx for Change (http://rxforchange.ucsf.edu). She has authored 175 peer-reviewed publications, serves on the Editorial Board of JAMA Internal Medicine, and is on the advisory board for Optum’s Quit for Life Tobacco Quitline. Dr. Prochaska is President of the Society for Research on Nicotine and Tobacco (SRNT), the international scientific society aimed at stimulating the generation and dissemination of new knowledge concerning nicotine and tobacco from bench to bedside and through to health policy. Conference Seminar 110 - NCI Shady Grove 9609 Medical Center Drive Rockville MD 20850 Judith Prochaska, PhD, MPH chesnut@imsweb.com America/New_York public

Judith (Jodi) Prochaska, PhD, MPH, is Associate Professor of Medicine with the Stanford Prevention Research Center and a member of the Stanford Cancer Institute. Dr. Prochaska is a Principal Investigator on multiple research awards from the National Institutes of Health and the State of California Tobacco-Related Disease Research Program. Her research program is leveraging technology (e.g., web, text, social media) to bring tobacco cessation treatment into novel settings and to populations with high smoking prevalence. With attention to medical education and clinical practice, Dr. Prochaska has disseminated tobacco treatment curricula as part of Rx for Change (http://rxforchange.ucsf.edu). She has authored 175 peer-reviewed publications, serves on the Editorial Board of JAMA Internal Medicine, and is on the advisory board for Optum’s Quit for Life Tobacco Quitline.

Dr. Prochaska is President of the Society for Research on Nicotine and Tobacco (SRNT), the international scientific society aimed at stimulating the generation and dissemination of new knowledge concerning nicotine and tobacco from bench to bedside and through to health policy.